Food and Drug Administration (FDA) authorized Moderna’s and Pfizer’s COVID-19 shots for children as young as 6 months old, on Friday, making nearly every person in the US eligible for vaccination
• Hospitalizations of kids under age 5 spiked during the winter omicron wave
The Food and Drug Administration (FDA) authorized Moderna’s and Pfizer’s COVID-19 shots for children as young as 6 months old, on Friday, making nearly every person in the US eligible for vaccination.
For the Moderna COVID-19 Vaccine, the FDA amended the emergency use authorization (EUA) to include the use of the vaccine in individuals 6 months through 17 years of age. The vaccine had been authorized for use in adults 18 years of age and older.
For the Pfizer-BioNTech COVID-19 Vaccine, the FDA amended the EUA to include the use of the vaccine in individuals 6 months through 4 years of age. The vaccine had been authorized for use in individuals 5 years of age and older.
FDA Commissioner Robert M. Califf said, “Those trusted with the care of children can have confidence in the safety and effectiveness of these COVID-19 vaccines and can be assured that the agency was thorough in its evaluation of the data.”
Although Covid is generally less severe in children than adults, hospitalizations of kids under age 5 spiked during the winter omicron wave, hitting the highest level of the pandemic.